Serial proton magnetic resonance spectroscopy (MRS) 
Introduction
An important unresolved question about the pathogenesis of multiple sclerosis is when does demyelination occur? Though it has long been known that both inflammation and demyelination can be present in the same lesion (Frommann, 1867; Charcot, 1868; Dawson, 1916; Lumsden, 1970; Allen, 1991) , the temporal pattern of evolution of each of these processes has not been elucidated by pathological studies which provide information only at a single time point. Serial MRI studies (Kermode et al., 1990) have shown that the earliest detectable event in the development of a new lesion is a breakdown of the blood-brain barrier; there is experimental (Hawkins et al., 1990) and post-mortem evidence (Katz et al., 1990 (Katz et al., , 1993 ) that this indicates the presence of inflammation. However, conventional MRI has not yielded information about the time course of demyelination since it does not reveal normal myelin or myelin breakdown products.
Proton magnetic resonance spectroscopy (MRS) at long echo times (TEs) of 135 and 270 ms detects metabolites with long T 2 relaxation times, such as jV-acetylaspartate (NAA), choline containing compounds, creatine/phosphocreatine and lactate.
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Proton MRS at short TEs of 10-30 ms detects additional metabolites with short T 2 relaxation times. These include mobile lipids, proteins, inositol, glucose and a number of the neurotransmitters such as glutamate and glutamine. The ability to detect mobile lipid resonances within multiple sclerosis lesions using proton MRS would provide, for the first time, a noninvasive tool with which to monitor myelin breakdown and to study the temporal relationship of inflammation and demyelination in vivo.
It has also been suggested that proton MRS may have a role in monitoring axonal loss (probably an important factor in the development of persistent disability in multiple sclerosis) since NAA, an amino acid clearly visible on proton MRS, is largely confined to neurons and their processes.
Recent technical advances in proton spectroscopy have improved its spatial resolution, allowing the study of volumes as small as 1 ml (Frahm et al., 1990 )-a common size for multiple sclerosis lesions. We have therefore carried out serial long and short TE proton MRS on patients with MRI or symptomatic evidence of acute cerebral lesions. Our aims were (i) to determine whether my el in breakdown products are spectroscopically detectable at short TEs within the acute lesion; (ii) if they are, whether they are the result of voxel contamination from overlying scalp; (iii) to establish at what phase in the evolution of the lesion demyelination occurs; (iv) to elucidate the time course of changes in NAA.
Material and methods Subjects
Eight patients (age range 20-48 years; mean age 28 years) were studied. Six patients had clinically definite multiple sclerosis and two had laboratory supported definite multiple sclerosis (Poser et al., 1983) . The disease severity ranged from mild to severe as measured on the expanded disability status scale (Kurtzke, 1983) . Two patients had undergone treatment with intravenous methylprednisone 1 day prior to the first spectroscopic examination. Nevertheless, these lesions still enhanced after administration of gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA) (Magnevist, Schering) . The patients were followed at 1-2 monthly intervals. Follow-up ranged from 4 to 9 months (mean 6 months). The patients were examined neurologically by one of the authors (C.A.D.) at entry into the study and at each follow-up session. The patients then underwent unenhanced MRI, localized proton MRS and finally Gd-DTPA enhanced MRI.
The study was approved by the Joint Ethics Committee at the Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London. Informed consent was obtained from all patients prior to each study. The patients were judged to have an acute lesion (i) if there was an area of increased signal intensity within white matter on MRI which displayed Gd-DTPA enhancement and which had not been present on MRI carried out in the previous month (four patients who had undergone monthly unenhanced and enhanced brain scans over the previous year as part of other longitudinal studies) or (ii) if there had been an acute clinical relapse within the previous 2 weeks and there was an appropriately placed new lesion on MRI which enhanced after Gd-DTPA administration (four patients).
Eight healthy age-matched controls underwent MRI and localized proton MRS without administration of Gd-DTPA. A 17-year-old female with a lipoma in the quadrigeminal cistern was also studied.
Magnetic resonance imaging and spectroscopy
Both MRI and MRS were performed on a 1.5 T GE signa whole body scanner using a standard quadrature head coil. The study commenced with a T 2 -weighted fast spin echo-imaging sequence [repetition time (TR) 3000 ms, fast TE (TEf) 80 ms] (5 mm slices with 2.5 mm gap, 256x256 matrix, echo train length 8). After imaging, a volume of interest ranging between 3.5 and 12 ml was prescribed which in the patient group incorporated a new high signal lesion. Large lesions were chosen in order to minimize partial volume effects. An MRI of the voxel was then obtained to ensure accurate localization. Water suppressed 'H spectra were obtained using a stimulated echo-acquisition mode (STEAM) sequence (Frahm et al., 1987 (Frahm et al., , 1989a . Acquisition parameters were TR 2000 ms, mixing time (TM) 12ms, TE 10 and 135 ms. The 256 averages were collected using an eight-step phase cycle in -9 min. Points collected were 1024, with a spectral width of 750 Hz. Shimming to a line width of ~ 3 Hz and water suppression were reoptimized for each new location. In the control group, spectra were collected from an area of periventricular white matter.
In the patient group, long and short TE spectra were acquired from acute lesions on the first study and at all subsequent examinations. At the first study only, a separate location containing normal appearing white matter was also examined which was lateral to the lesion and closer to the scalp. After collection of the spectroscopic data, Gd-DTPA, 0.1 mM/kg was injected intravenously and T,-weighted Gd-DTPA enhanced images were obtained (TR 500 ms, TE 40 ms).
Data processing included 1.5 Hz line broadening for filtering, Fourier transformation and zero order phase correction. No baseline correction was applied. Resonance areas were calculated by manual integration. Ratios for the various metabolites are expressed relative to creatine. The NAA and choline ratios were calculated from the spectra collected at 135 ms. Inositol ratios were calculated from spectra collected at 10 ms. Statistical analysis was performed using Student's t test. Values are expressed ± 1 SD.
Results
Representative short echo and long echo spectra from a healthy 28-year-old female control are shown in Fig. 1A . AS we have reported previously (Davie et al., 1992) all spectra collected at a short TE from controls showed small resonances at 1.3 and 0.9 p.p.m. which have been assigned respectively to the methylene and methyl groups of lipid (May et al., 1986) . These assignments are corroborated by an experimental model, showing that signals appear at 0.9 and 1.3 p.p.m. in the proton spectrum after the induced formation of lipid droplets in myeloma cells (Callies et al., 1993) . In vivo confirmation of these assignments were obtained from the 17-year-old female patient with a lipoma situated in the quadrigeminal plate (Fig. 1B) ; large resonances were seen only at 0.9 and 1.3 p.p.m. (Fig. lc) .
A spectrum at a TE of 135 ms confirmed that there was no contribution from lactate in the resonance at 1.3 p.p.m. in healthy controls (Fig. 1A) . Lipid resonances were not observed at this longer TE.
Resonances from the other metabolites have been assigned as follows (Frahm a al., 1989b; Behar and Ogino, 1991) Fig. 1 A, proton spectra from a healthy 28-year-old female control taken from periventncular white matter. The upper spectrum is at TE of 10 ms. The lower spectrum is at a TE of 135 ms. Cho = choline; Cr = creatine; Ins = inositol; NAA = AZ-acetylaspartate. B, C, T r weighted NMR scan (TR 3000 ms, TE f 80 ms) and short echo spectrum (TR 2 s, TE 10 ms) from a 17-year-old female with a lipoma in the quadrigeminal cistern. The spectrum taken from a voxel centred on the lipoma shows resonances from the methyl lipid group at 0.9 p.p.m. and from the methylene group at 1.3 p.p.m.
Short echo time spectra: patients
Short echo spectra in the patient group showed large resonances at 0.9 and 1.3 p.p.m. from Gd-DTPA enhancing lesions (Fig. 2) , when compared with the small resonances seen in the regions of normal appearing white matter lateral to the lesion and in white matter from healthy controls. In one 36-year-old female with clinically definite multiple sclerosis it was possible to study a number of volumes from the lesion and surrounding normal appearing white matter. A spectrum (Fig. 3 , spectrum A) was collected from a 12 ml volume which included most of a region of high signal as shown on a T 2 -weighted scan (Fig. 3, image A) . When the voxel was reduced to a volume of 4 ml and taken from the centre of the lesion (Fig. 3, image  B) , the changes were far more striking (Fig. 3, spectrum B) ; this region was subsequently shown to enhance (Fig. 3, image  D) . A spectrum obtained from a 4 ml volume incorporating part of the lesion lateral to the region of enhancement and including normal appearing white matter (Fig. 3 , spectrum c and image c) showed only small lipid resonances, consistent with the evidence that these non-enhancing areas surrounding enhancing active lesions are the result of oedema (Larsson et al., 1988; McDonald et al., 1992) . In addition, the small size of these lipid signals (which are at control levels) from a volume nearer the scalp makes it highly unlikely that the large resonances from the centre of the lesion are due to contamination from scalp fat.
In seven patients, these abnormal lipid signals gradually resolved to control levels in from 4 to 8 months (mean ~5 months) (Fig. 4) , whereas Gd-DTPA enhancement had ceased in all patients by 2 months. One patient followed to date, for only four months, still has increased lipid resonances.
In three of the patients there was the suggestion of a separate resonance seen at 1.4 p.p.m. (Fig. 5) . This resonance was only visible at relatively short TEs reflecting the short T 2 of its components.
Inositol/creatine ratios were elevated within acute enhancing lesions (0.95 ±0.16) compared with areas of normal appearing white matter (0.7±0.1, P < 0.01) and white matter from healthy age matched controls (0.62±0.2, P < 0.003). The inositol/creatine ratio in the lesion group remained elevated throughout follow-up. There was no significant difference between inositol/creatine ratios in the control group and normal appearing white matter (P < 0.2).
Long echo time spectra: patients
There was a reduction of NAA/creatine ratios in acute enhancing lesions (1.35±0.27, P = 0.001) and normal appearing white matter (1.6 ±0.22, P < 0.02), compared with controls (1.84 ±0.2). In five of these lesions there was a subsequent further reduction in NAA/creatine ratios (mean 1.16 ±0.15) with maximum reduction seen between 1 and 4 months (mean 2.2 months). In six of the lesions, there was a later rise in the NAA/creatine ratio which began between 4 and 6 months (Fig. 6) . The mean NAA/creatine ratio at presentation in these six lesions was 1.41 ±0.27 falling to 1.1 ±0.15 (P = 0.006) between 1 and 4 months and rising to 1.57 ±0.22 (P = 0.001) between 4 and 8 months. The mean NAAycreatine ratio in all eight lesions over time is shown in Fig. 7 .
The mean choline/creatine ratio in the lesions when first studied was elevated (1.26 ±0.26). This was significantly greater than in normal appearing white matter, (0.82±0.13, P = 0.006) and controls (0.92 ±0.08, P = 0.01). With followup the choline/creatine ratio returned to control levels in five out of eight lesions over 2-6 months. Although the mean choline/creatine ratio was lower in normal appearing white matter compared with controls, this was not statistically significant (P < 0.09).
Two of the lesions showed evidence of lactate production. In one, lactate was visible at the first study, 3 weeks after symptom onset. Spectroscopy 1 month later, after Gd-DTPA enhancement had ceased, showed resolution of the lactate peak. In the second patient, spectra acquired from a large enhancing lesion 10 days after symptom onset showed no lactate signal. However, lactate was visible 1 month later when Gd-DTPA enhancement had ceased. The lactate signal was no longer visible on spectroscopy 10 weeks after symptom onset.
Discussion
The outstanding findings in this study are the regular detection of small lipid resonances in normal white matter using short echo time proton spectroscopy, the marked increase in lipid resonances in association with the inflammatory phase of the new multiple scerosis lesion and the partially reversible reduction in the NAA/creatine ratio in new multiple sclerosis lesions. 
Increased lipid resonances and the course of demyelination
We have shown that small resonances at 0.9 and 1.3 p.p.m. are a consistent finding in normal white matter of healthy individuals and multiple sclerosis patients. However, in large acute multiple sclerosis lesions, there was a marked increase in these resonances which have been assigned to the methyl and methylene groups of lipid, respectively (Callies et al., 1993) . Some investigators (Wolinsky et al., 1990; Larsson et al., 1991; Davie etai, 1993; Koopmans etai, 1993) have observed increased resonances from multiple sclerosis lesions which have been attributed to mobile lipid, while others have not Grossman et al., 1992; Poser et al., 1992) . When lipid peaks have been described, no consistent relationship has hitherto emerged, either with the apparent age of the lesion or the presence of Gd-DTPA enhancement (Narayana et al., 1992) . Systematic serial observations have not, however, been performed. Moreover, doubts have arisen as to whether the lipid peaks described have been due to extra-voxel contamination from the scalp. In the present study, two observations strongly suggest that these elevated peaks are not the result of scalp contamination: first, they were consistently and markedly higher in the acute lesions than from an area of normal appearing white matter closer to the scalp; secondly, they consistently decreased towards normal levels over several months.
There are a number of possible reasons why previous studies have not revealed increased lipid resonances in multiple sclerosis lesions. First, the lesions studied were often small and the voxels could have included a considerable proportion of normal appearing white matter resulting in partial volume effects. In the present study, we concentrated on large lesions in order to avoid this problem. Secondly, a number of the non-enhancing lesions may have been chronic and the present study shows that abnormal lipid peaks will have disappeared in most lesions older than 6 months. Thirdly, a number of published studies have used TEs of 20-30 ms. Lipid has a very short T 2 (Fig. 5 ) and the increased signal may therefore not be as obvious at these slightly longer TEs, especially if the lesions are several months old.
In the present study, increased lipid resonances were seen in all lesions which displayed Gd-DTPA enchancement. Indeed, when lesion size allowed more precise resolution, this increase was maximal in areas of enhancement (Fig. 3, spectrum B) . Four lesions had not been apparent with or without enhancement on scans in the previous 4 weeks. Since in multiple sclerosis, enhancement indicates an increase in permeability of the blood-brain barrier in association with inflammation (Katz etal., 1990 (Katz etal., , 1993 Kermode et al., 1990) we infer that demyelination occurs during the inflammatory phase of lesion development. Just how early in this phase it occurs, or whether it might precede it, is unknown, though recent observations on acute optic neuritis have shown that delayed evoked potentials (indicating the presence of demyelination) can be seen in enhancing lesions within 48 h of the onset of symptoms (S. Jones, R. Kapoor and W. I. McDonald, unpublished observations). Since enhancement is the earliest detectable event in the evolution of a new lesion and may precede the onset of symptoms (Barratt et al., 1988) , we conclude that demyelination occurs early in its development.
Increased lipid peaks were detectable in new lesions for 4 -8 months. Histopathological studies of demyelination (Adams et al., 1989) have shown lipid, in the form of triglyceride and cholesterol ester, in lesions which have been symptomatic for up to 26 weeks. Similar observations in cerebral infarction (Stehbens, 1972) show lipid laden macrophages which are detectable for a minimum of 3 months and in larger lesions for several years. The time course of increased lipid signal detected by proton MRS is thus compatible with the histologically determined time course of disappearance of lipid laden macrophages from areas of acute myelin destruction. Such destruction is, of course, not peculiar to multiple sclerosis and it is likely that abnormal lipid resonances will be found in a wide range of pathological conditions, including vascular and granulomatous disorders. Whether a pattern of spectral changes will emerge which is characteristic of multiple sclerosis remains to be seen.
A number of the acute lesions studied showed a resonance at 1.4 p.p.m. This resonance was more prominent at TEs of 20 and 30 ms (Fig. 5) , indicating that it has a longer T 2 than the methylene group at 1.3 p.p.m. It is at present uncertain which metabolite this signal is due to, though the polypeptide thymosin /34, found in macrophages and in a subset of oligodendrocytes, produces resonances at this region of the spectrum (Kauppinen et al., 1992) . There is some preliminary evidence that other macromolecules, e.g. myelin basic protein, may also produce resonances in this part of the spectrum (S. Davies, unpublished observations).
Reversible reduction in NAA/creatine ratio
Previous studies have reported a reduction in NAA/creatine ratios both in acute (Miller et al., 1991; Arnold et al., 1992; Bruhn et al., 1992) and chronic lesions (Matthews et al., 1991; Van Hecke et al., 1991) in multiple sclerosis. The function of NAA is unknown. It is found almost exclusively in neurons and their processes in the adult brain (Birken and Oldendorf, 1989; Simmons et al., 1991) though it has also been found in the oligodendrocyte type 2 astrocyte progenitor cells (Unrejak et al., 1993) . It has been suggested that the reduced NAA/creatine ratio in multiple sclerosis lesions is due to axonal loss which in chronic multiple sclerosis lesions may be extensive (Adams et al., 1989) though it is only exceptionally so in acute lesions. In this study we observed a reduction in NAA/creatine ratios in acute lesions (Arnold, 1992) which was partially reversible over 4-8 months. A simple loss of axons cannot account for these reversible changes. A number of factors may be involved. First, alterations in the chemical environment of the lesion could alter the relaxation times of NAA, thus affecting signal intensity. However, this is unlikely. If one assumes a T! value of 1500 ms for normal cerebral white matter (Frahm et al., 19896) , it would require a 75% increase in the T[ of a lesion to explain the reduction in NAA signal we have observed. Such a change is improbable and spectroscopy of animals with acute experimental allergic encephalomyelitis has shown no changes in the T, or T 2 values of NAA (Inglis et al., 1992) . Secondly, we and others have used creatine/phosphocreatine as an internal standard of reference, since these two compounds are in chemical equilibrium and their total concentration should accordingly remain constant. Frahm et al. (19896) have calculated the cerebral concentration of total creatine as between 10 and 11 mM. If there were a reduction in the total creatine concentration which continued to fall after stabilization of NAA levels, the NAA/creatine ratio would rise. This hypothesis is not, however, in keeping with a study using phosphorus MRS in which there was an increase in phosphocreatine levels in multiple sclerosis lesions compared with healthy controls (Minderhoud et al., 1992) .
Thirdly, oedema is a prominent feature of the acute multiple sclerosis lesion (McDonald et al., 1992) and it is possible that the relative number of axons per unit volume in the white matter affected by the lesion is at first reduced and later increases as the oedema is absorbed. Another possibility which is testable experimentally, is that the function of the mitochondria (where NAA is formed) (Patel and Clark, 1979 ) is reversibly impaired during inflammation. Finally, there is the possibility that adult oligodendrocyte type two astrocyte progenitor cells containing NAA proliferate locally or migrate into the lesion in order to promote remyelination. Though the latter is extensive in some lesions (Prineas et al., 1993) , it is not in others, and whether the magnitude of the change in NAA can be accounted for in this way is unknown.
Other observations
The increase in choline/creatine has previously been interpreted as evidence for demyelination because of the abundance of choline-containing compounds in myelin. They are, however, abundant in all cell membranes (McDwain and Bachelard, 1985) and as the study of acute experimental allergic encephalomyelitis (in which there is inflammation, but no demyelination) shows (Brenner et al., 1993) , a large increase in the choline/creatine ratio can be produced by the increased membrane turnover associated with inflammatory cellular infiltration. This is likely to contribute to the changes in the choline/creatine ratio we and others have observed (Matthews et al., 1991) .
The elevation in the inositol/creatine ratio in the lesion group is in agreement with previous studies Koopmans et al., 1993) . The function of inositol (an osmolyte) is uncertain and it is not yet clear why the inositol/creatine ratio is increased in multiple sclerosis.
Implications for monitoring therapy
The reliable detection of lipid breakdown by spectroscopy has implications for monitoring treatment in multiple sclerosis. /SInterferon reduces the frequency of evidence of new disease activity as judged by unenhanced MRI (IFNB Multiple Sclerosis Study Group, 1993 , but its mechanism of action is uncertain. It will be important to determine whether it (and future putative therapeutic agents) have differential effects on inflammation and demyelination. The former can be assessed by Gd-DTPA enhanced MRI, and the latter now by short echo time proton MRS. The observation of abnormalities in normal appearing white matter is probably due to the presence of microscopic demyelination (Allen, 1991) and is thus a potential measure of the extent of the disease process and possibly a prognostic indicator. Accordingly, it will be important to monitor not only the visible lesions, but the apparently uninvolved white matter as well.
